NFIL3T

Nayan Jain1, Yuzhe Shi1, Celina May2

  • 1Columbia University Medical Center New York United States.

Cancer discovery
|February 26, 2026
PubMed
概括

NFIL3驱动CAR T细胞的功能障碍,限制它们对固体瘤的有效性. 破坏NFIL3可增强CAR T细胞的持久性和抗瘤活性,为癌症免疫治疗提供了一个新的治疗点.